https://health-union.com/wp-content/uploads/2019/07/BladderCancerRecurrence-TheFearThatFollows@2x.png
560
1800
Lina Kirby
/wp-content/uploads/2021/06/health-union-logo-07-300x90-1.png
Lina Kirby2019-07-16 10:50:582021-02-12 10:35:34Females with Bladder Cancer Receive Less Support Than MenPeruse Health Union’s latest news announcements on survey findings, awards, leadership, and more. News media interested in learning more about how Health Union can help them tell the health stories they want to tell can visit our Press Kit and Resource Center for News Media.
https://health-union.com/wp-content/uploads/2019/07/BladderCancerRecurrence-TheFearThatFollows@2x.png
560
1800
Lina Kirby
/wp-content/uploads/2021/06/health-union-logo-07-300x90-1.png
Lina Kirby2019-07-16 10:50:582021-02-12 10:35:34Females with Bladder Cancer Receive Less Support Than Men
https://health-union.com/wp-content/uploads/2019/07/MD-IA-press-release-2019.png
280
900
Lina Kirby
/wp-content/uploads/2021/06/health-union-logo-07-300x90-1.png
Lina Kirby2019-07-08 11:04:252023-05-05 10:05:51People with Macular Degeneration Positively Impacted by Retina Specialists
https://health-union.com/wp-content/uploads/2019/06/SC-IA-press-release-2019.png
280
900
Lina Kirby
/wp-content/uploads/2021/06/health-union-logo-07-300x90-1.png
Lina Kirby2019-06-20 09:58:332021-02-12 10:37:55Skin Cancer Recurrence Linked to More Risk Factors
https://health-union.com/wp-content/uploads/2019/06/LC-IA-2019.png
280
900
Lina Kirby
/wp-content/uploads/2021/06/health-union-logo-07-300x90-1.png
Lina Kirby2019-06-12 13:00:152023-05-05 09:58:37Non-Smoking Lung Cancer Patients Diagnosed at Later Stages
Survey: Focal Seizures Lead to Complex Epilepsy Treatment Journey
Respondents with focal seizures were more likely than those who aren’t to currently be using prescription medications and various alternative therapies.
Survey: Treatment Plan Discussions Differ from Adherence Challenges
With the highest percentage, 27% of respondents said they viewed cost as a challenge to staying on their medication as prescribed or instructed.
Health Union Ranks No. 449 in 2021 Deloitte Technology Fast 500
Health Union ranked No. 449 on Deloitte’s 2021 Technology Fast 500™, continuing to experience exponential growth since the company started in 2010.
Quality of Life Impact Research Presented at Three Fall Conferences
The findings focus on the patient-reported impact of cystic fibrosis, hidradenitis suppurativa and spondyloarthritis on various quality of life factors.